{"id":"https://openalex.org/W1820332011","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.3611","title":"Quality of life (QOL) and toxicity among patients in CALGB 80405.","display_name":"Quality of life (QOL) and toxicity among patients in CALGB 80405.","publication_year":2013,"publication_date":"2013-05-20","ids":{"openalex":"https://openalex.org/W1820332011","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.3611","mag":"1820332011"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.15_suppl.3611","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.3611","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.3611","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059087982","display_name":"Michelle Joy Naughton","orcid":"https://orcid.org/0000-0001-6037-1522","observed_orcids":["https://orcid.org/0000-0001-6037-1522"]},"institutions":[{"id":"https://openalex.org/I4405269449","display_name":"Wake Forest University Health Sciences","ror":"https://ror.org/046r1r105","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]},{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle Joy Naughton","raw_affiliation_strings":["Wake Forest University, School of Medicine, Winston-Salem, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wake Forest University, School of Medicine, Winston-Salem, NC","institution_ids":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088893766","display_name":"Deborah Schrag","orcid":"https://orcid.org/0000-0002-4334-5717","observed_orcids":["https://orcid.org/0000-0002-4334-5717"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deborah Schrag","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA","Dana-Farber Cancer Institute, Boston, MA#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA#TAB#","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037875642","display_name":"Alan Paul Venook","orcid":"https://orcid.org/0000-0001-9749-6548","observed_orcids":["https://orcid.org/0000-0001-9749-6548"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan Paul Venook","raw_affiliation_strings":["Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073130519","display_name":"Donna Niedzwiecki","orcid":"https://orcid.org/0000-0002-3566-0450","observed_orcids":["https://orcid.org/0000-0002-3566-0450"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donna Niedzwiecki","raw_affiliation_strings":["Duke University, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019453350","display_name":"Roger T. Anderson","orcid":"https://orcid.org/0000-0001-8112-4117","observed_orcids":["https://orcid.org/0000-0001-8112-4117"]},"institutions":[{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roger T. Anderson","raw_affiliation_strings":["Penn State College of Medicine, Hershey, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Penn State College of Medicine, Hershey, PA","institution_ids":["https://openalex.org/I130769515"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045441776","display_name":"Heinz\u2010Josef Lenz","orcid":"https://orcid.org/0000-0003-2178-9568","observed_orcids":["https://orcid.org/0000-0003-2178-9568"]},"institutions":[{"id":"https://openalex.org/I4210117038","display_name":"USC Norris Comprehensive Cancer Center","ror":"https://ror.org/01nmyfr60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800154431","https://openalex.org/I4210117038"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heinz-Josef Lenz","raw_affiliation_strings":["University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA","institution_ids":["https://openalex.org/I4210117038"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109904010","display_name":"Stephen S. Grubbs","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen S. Grubbs","raw_affiliation_strings":["Helen F. Graham Cancer Center at Christiana Care, Newark, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Helen F. Graham Cancer Center at Christiana Care, Newark, DE","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"15_suppl","first_page":"3611","last_page":"3611"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.02290000021457672,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.00989999994635582,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.9459999799728394},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.7919999957084656},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9919999837875366},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.8479999899864197},{"id":"https://openalex.org/keywords/acneiform-rash","display_name":"acneiform rash","score":0.746999979019165},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.609000027179718},{"id":"https://openalex.org/keywords/folfox","display_name":"FOLFOX","score":0.859000027179718},{"id":"https://openalex.org/keywords/folfiri","display_name":"FOLFIRI","score":1.0},{"id":"https://openalex.org/keywords/eortc-qlq-c30","display_name":"EORTC QLQ-C30","score":0.8700000047683716},{"id":"https://openalex.org/keywords/social-functioning","display_name":"social functioning","score":0.7239999771118164},{"id":"https://openalex.org/keywords/appearance-concerns","display_name":"appearance concerns","score":0.8379999995231628},{"id":"https://openalex.org/keywords/kras-wild-type-tumors","display_name":"KRAS wild-type tumors","score":0.734000027179718},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.3449999988079071}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9411909580230713},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.871881365776062},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.7658390402793884},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6135599613189697},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.5694879293441772},{"id":"https://openalex.org/C2776705615","wikidata":"https://www.wikidata.org/wiki/Q1389369","display_name":"FOLFIRI","level":5,"score":0.5445395708084106},{"id":"https://openalex.org/C2778260052","wikidata":"https://www.wikidata.org/wiki/Q117636","display_name":"FOLFOX","level":5,"score":0.5189818739891052},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.5147788524627686},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5123618841171265},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.4995076656341553},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4220130443572998},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.4174920320510864},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3579069674015045},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3523898124694824},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3494555950164795},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.33212488889694214},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3293072581291199},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.09728732705116272},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.15_suppl.3611","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.3611","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.3611","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2538058947","https://openalex.org/W2883608615","https://openalex.org/W2589326493","https://openalex.org/W3000162308","https://openalex.org/W2589485659","https://openalex.org/W2604348276","https://openalex.org/W3179204113","https://openalex.org/W2082958570","https://openalex.org/W2518843616","https://openalex.org/W3041815418"],"abstract_inverted_index":{"3611":[0],"Background:":[1],"CALGB":[2,74],"80405,":[3],"a":[4,45,59,152,171],"phase":[5],"III":[6],"trial,":[7],"was":[8,98],"originally":[9],"designed":[10],"to":[11,73,81,92,212,228,291,300,316],"compare":[12],"toxicity":[13],"and":[14,30,40,56,89,104,107,115,138,165,216,237,271,287],"overall":[15,140],"survival":[16,318],"of":[17,26,119,155,187,251],"metastatic":[18],"colorectal":[19],"patients":[20,71,93,126,241],"treated":[21],"with":[22,94,133],"standard":[23],"chemotherapy":[24,252],"(choice":[25],"FOLFOX":[27],"or":[28,36,184,245,254],"FOLFIRI)":[29,255],"either:":[31],"1)":[32],"Bevacizumab;":[33],"2)":[34],"Cetuximab;":[35],"3)":[37],"both":[38],"Bevacizumab":[39,229,297],"Cetuximab.":[41],"Because":[42],"Cetuximab":[43,128,243,246,282,307],"causes":[44],"prominent":[46],"acneiform":[47],"skin":[48,204,213,232,293,304],"rash,":[49],"adverse":[50],"effects":[51],"on":[52,259],"QOL":[53,60,64,97,141,288],"were":[54,157,176,199,274],"anticipated":[55],"assessed":[57,99],"in":[58,179,203,208],"companion.":[61],"Methods:":[62],"The":[63,249],"companion":[65],"enrolled":[66],"the":[67,78,85,112,116,188,224,321],"first":[68],"518":[69],"consenting":[70],"randomized":[72,227],"80405":[75],"between":[76,320],"10/2005-9/2007,":[77],"majority":[79],"prior":[80],"amendments":[82],"that":[83,125],"eliminated":[84],"dual":[86],"biologic":[87],"arm":[88],"restricted":[90],"participation":[91],"KRAS":[95],"wttumors.":[96],"at":[100,142,190],"baseline,":[101],"6":[102,106],"weeks,":[103],"3,":[105],"9":[108],"months":[109,192],"post-randomization,":[110],"using":[111],"EORTC":[113,189],"QLQ-30":[114],"Dermatology-Specific":[117],"Quality":[118],"Life":[120],"(DSQL)":[121],"Scale.":[122],"We":[123],"hypothesized":[124],"receiving":[127,242,296],"would":[129],"have":[130],"lower":[131,139],"satisfaction":[132],"appearance,":[134],"reduced":[135],"social":[136,209,235,270],"functioning":[137,182],"3":[143,172,191],"months,":[144],"(a":[145],"primary":[146],"assessment":[147],"point).":[148],"Results:":[149],"Patients":[150,226],"had":[151,256],"mean":[153],"age":[154],"59,":[156],"predominantly":[158],"male":[159],"(58%),":[160],"performance":[161],"status":[162],"0":[163],"(62%),":[164],"non-Hispanic":[166],"White":[167],"(85%).":[168],"83%":[169],"completed":[170],"month":[173],"assessment.":[174],"There":[175],"no":[177,257],"differences":[178,198,319],"global":[180],"health":[181],"(p=0.164)":[183],"other":[185],"items/subscales":[186],"by":[193,223],"treatment":[194,279,308],"arm.":[195],"However,":[196,281],"significant":[197],"found":[200],"across":[201,278],"arms":[202],"symptoms":[205,286],"(p<.0001),":[206,220],"limitations":[207,236],"activities":[210],"due":[211],"condition":[214],"(p=0.008),":[215],"concerns":[217,239,289],"about":[218],"appearance":[219,238],"as":[221,265,267],"measured":[222],"DSQL.":[225],"reported":[230,284],"fewer":[231,234],"symptoms,":[233],"than":[240,294],"alone":[244],"+":[247],"Bevacizumab.":[248],"choice":[250],"(FOLFOX":[253],"bearing":[258],"these":[260],"results.":[261],"Conclusions:":[262],"Global":[263],"QOL,":[264],"well":[266],"physical,":[268],"role,":[269],"emotional":[272],"functioning,":[273],"not":[275],"significantly":[276],"different":[277],"arms.":[280],"recipients":[283],"greater":[285],"relating":[290],"their":[292],"those":[295],"alone.":[298],"Interventions":[299],"more":[301],"adequately":[302],"address":[303],"problems":[305],"from":[306],"are":[309,312],"warranted.":[310],"Participants":[311],"still":[313],"being":[314],"followed":[315],"determine":[317],"biologics.":[322],"Clinical":[323],"trial":[324],"information:":[325],"NCT00265850.":[326]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}